The KR4-HeLa fusion cell lines and EBV-infected human breast cancer cell lines expressed much lower LMP1 levels than the EBV-positive LCLs; however, they also had lower sumo levels than the EBV-positive B-cells. Here, PDLIM7 is linked to breast carcinoma.